Indoco has gained permission from the Food and Drug Administration for lofexidine tablets 0.18 mg, which is a generic of USWM’s Lucemyra Tablets. Indoco has been granted a Competitive Generic Therapy ...

Indoco Remedies Ltd. Annual stock financials by MarketWatch. View the latest INDOCO financial statements, income statements and financial ratios.

Indoco Remedies releases figures for Q4 on May 16. Analysts predict earnings per share of INR 1.85. Track Indoco Remedies stock price in real-time on Markets Insider here. On May 16, Indoco Remedies ...

Indoco Remedies Ltd (BOM:532612) reported a significant increase in net revenues for Q2 FY26, with standalone net revenues at INR 4,293 million, reflecting an 8.8% growth compared to the previous ...

INDOCO REMEDIES LTD - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Rediff MoneyWiz, the ...

Earnings call Indoco Remedies reported consolidated revenue of INR 4,718 million in Q2 FY26, up 9.6% YoY and 9.5% QoQ. EBITDA margins improved significantly to 9.1% from 4.1% in Q1. Management expects ...

Indoco Remedies Limited (Indoco), a fully integrated, research-oriented pharmaceutical company, announced that it has received the Establishment Inspection Report (EIR) from the United States Food and ...

Regulations, 2011 - Rediff MoneyWiz, the personal finance service from Rediff.com equips the user with tools and information ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.